Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.
about
Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasisOvarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolismMospd1, a new player in mesenchymal versus epidermal cell differentiationβ-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroidsNeoplasia: the second decade.Identification of novel candidate genes for follicle selection in the broiler breeder ovary.Characterization of three new serous epithelial ovarian cancer cell lines.Role of malignant ascites on human mesothelial cells and their gene expression profilesSOX2 is required to maintain cancer stem cells in ovarian cancer.STAT3 and epithelial-mesenchymal transitions in carcinomasModeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer.Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients.Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancerCirculating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites.EphB6 receptor modulates micro RNA profile of breast carcinoma cellsDerivation and characterization of matched cell lines from primary and recurrent serous ovarian cancerTribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease.Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.Acellular fraction of ovarian cancer ascites induce apoptosis by activating JNK and inducing BRCA1, Fas and FasL expression in ovarian cancer cells.A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer.Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironment.Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1).Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring.Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy.Profiling of cytokines in human epithelial ovarian cancer ascites.Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary diseaseMeeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosisOvarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosisEmpirical chemosensitivity testing in a spheroid model of ovarian cancer using a microfluidics-based multiplex platform.Identification of tribbles-1 as a novel binding partner of Foxp3 in regulatory T cellsOrganotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasisCross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.The impact of T-cell immunity on ovarian cancer outcomes.CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signalingAiming to immune elimination of ovarian cancer stem cellsBreast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4.The War on Cancer rages on.
P2860
Q26851836-67F13AA6-A4EA-413A-B6C4-A2273F9BF4D7Q28538384-AB087069-02B1-4387-945A-1AC1818897BEQ28594736-74CA1FC6-96DE-4033-9B6B-F289FB29D60DQ30370274-B0F73423-61F3-441F-9B45-9EB4D36D1AE0Q30484000-D29FB9A2-6131-449A-816B-F631EAB0573CQ31094355-D30C231A-548E-4A9F-9B2C-2D5C7A746C86Q33338286-1E7B377E-639E-45C8-B7F7-BC860FCCF5A8Q33559857-83974E95-4543-4A49-B833-4585D72480CEQ33607622-F84DD127-25C6-4337-AAD4-FC0C41928B69Q33623947-6B9DE07E-458A-481F-B1FF-337EEE2D19CEQ33641924-2B846359-9113-48A3-8B4B-0BC1689D56E9Q33650479-D5BB7B6A-F3CE-437C-931D-21A79E616FB2Q33914512-48B98F20-D107-4114-8A26-ACED66CF1B42Q33940693-28D7DF19-4440-4774-A657-736E78158C63Q33946367-71181986-98D9-4C86-84D7-283FFE0FF49CQ33980005-A2A7E838-993B-4BCB-987A-A38A769AB09DQ34397197-F28DEA48-EEC8-4FFE-AD9F-7F5C1E610FFAQ34546438-4C71FA69-C44C-468D-AD37-B09773F8F224Q34738849-B66DCF00-E08F-4FB9-9023-5B53DFD3441DQ34781244-0D2E716A-BA03-49BD-8A6B-CD67F113487DQ34989150-7DA54143-9112-40B6-8294-424AB2EEB92FQ35098085-47B01395-9F44-497F-B87E-99502084681FQ35805622-DC14F3F9-A6F4-4116-A4DC-BCAC9847DF8EQ35837125-531E40C4-C0ED-4589-8DD5-A082CE4AC3B1Q35964621-A18CF9AC-D6AC-4AD6-97C2-0C4F1BE5C2BFQ36057153-64FCE4E1-5630-4C46-8E3A-AEAF8C17961FQ36206483-1757348E-EE44-4BD6-A210-53A292A246BDQ36248459-35476C70-5AE5-49D7-A392-FBBBBC874B81Q36358324-DDA1437B-89F2-4E33-9180-6335457F8E5BQ36427134-313C8035-C292-488E-B8DC-368AF62AB3B5Q36478459-1C1D7D95-6DB6-4134-8AFE-1B053EC0E2D4Q36564821-01346097-7746-4B66-AAA4-27353BDA9814Q36742098-5F5FBEC5-DB77-4733-A4D7-966142438EB3Q36837236-A0D166E8-26D0-460F-99BC-758602CCC61AQ37080992-FB69163C-3CED-410B-8B46-A12A6B6C60C2Q37118142-C1309A51-6660-49A5-AACF-08EBDBFCB505Q37244183-0FF2B856-3D5C-4055-8967-DB6C7917B08AQ37266548-86DF05D0-3D07-46D9-8D9B-86097D096C11Q37340332-0873AA6F-7084-41BB-9181-1EDE26357042Q37478602-53B858DB-1481-4A42-BDE3-5C1D5878DE4E
P2860
Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Characterization of ovarian ca ...... of epithelial ovarian cancer.
@ast
Characterization of ovarian ca ...... of epithelial ovarian cancer.
@en
type
label
Characterization of ovarian ca ...... of epithelial ovarian cancer.
@ast
Characterization of ovarian ca ...... of epithelial ovarian cancer.
@en
prefLabel
Characterization of ovarian ca ...... of epithelial ovarian cancer.
@ast
Characterization of ovarian ca ...... of epithelial ovarian cancer.
@en
P2093
P2860
P356
P1433
P1476
Characterization of ovarian ca ...... of epithelial ovarian cancer.
@en
P2093
Abdelali Filali-Mouhim
Anne-Marie Mes-Masson
Cécile Le Page
Diane M Provencher
Magdalena Zietarska
Marie-Line Puiffe
Mario Chevrette
Patricia N Tonin
Véronique Ouellet
P2860
P304
P356
10.1593/NEO.07472
P577
2007-10-01T00:00:00Z